NASDAQ: IMUXImmunic Inc Stock Ownership - Who owns Immunic?
Insider buying vs selling
Have Immunic Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when IMUX insiders and whales buy or sell their stock.
IMUX Shareholders
What type of owners hold Immunic Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aberdeen Group PLC | 60.52% | 8,243,941 | $127.62M | Institution |
| Bvf Inc | 56.18% | 7,652,972 | $118.47M | Institution |
| Avidity Partners Management LP | 54.10% | 7,369,352 | $114.08M | Institution |
| Muneer A. Satter | 52.36% | 7,132,277 | $110.41M | Insider |
| Vanguard Capital Management LLC | 37.72% | 5,138,316 | $79.54M | Institution |
| Soleus Capital Management LP | 33.04% | 4,500,000 | $69.66M | Institution |
| Laurion Capital Management LP | 28.50% | 3,882,162 | $60.10M | Institution |
| Millennium Management LLC | 27.75% | 3,779,922 | $58.51M | Institution |
| Morgan Stanley | 24.14% | 3,288,540 | $50.91M | Institution |
| Nantahala Capital Management LLC | 18.40% | 2,506,491 | $38.80M | Institution |
IMUX vs Biotech Stocks
Immunic Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.